Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 402,955 |
|
|||||
| News | - | ||||||
| Day High | 5.08 | Low High |
|||||
| Day Low | 4.72 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| ADC Therapeutics SA | ADCT | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.32 | 6.84% | 5.00 | 19:13:37 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 4.72 | 4.72 | 5.08 | 4.97 | 4.68 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 3,045 | 402,955 | $ 4.95 | $ 1,994,998 | - | 0.359908 - 6.04 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:23:49 | 2 | $ 4.99 | USD |
ADC Therapeutics SA Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 410.17M | 82.53M | - | 69.56M | -234.53M | -2.84 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
ADC Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ADCT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.33 | 5.08 | 4.3047 | 4.81 | 521,641 | 0.67 | 15.47% |
| 1 Month | 4.20 | 5.38 | 4.07 | 4.69 | 505,638 | 0.80 | 19.05% |
| 3 Months | 3.17 | 6.04 | 2.92 | 4.39 | 718,042 | 1.83 | 57.73% |
| 6 Months | 0.81 | 6.04 | 0.359908 | 2.90 | 709,303 | 4.19 | 517.28% |
| 1 Year | 2.08 | 6.04 | 0.359908 | 2.45 | 557,355 | 2.92 | 140.38% |
| 3 Years | 24.85 | 32.00 | 0.359908 | 6.69 | 426,329 | -19.85 | -79.88% |
| 5 Years | 30.00 | 56.5899 | 0.359908 | 10.83 | 383,930 | -25.00 | -83.33% |
ADC Therapeutics Description
| ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212. |
